Company Profile
Exact Sciences Stock Price, News & Analysis
Company overview
Business overview
Exact Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Exact Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Exact Sciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Exact Sciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
EXAS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Exact Sciences’ catalysts are Cologuard Plus progress, screening utilization, and any regulatory or commercial update that broadens the early-detection franchise. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.